Good afternoon and welcome to Markets Desk.
Supermicro shares surged roughly twenty percent after the company posted meaningful margin improvement, but seasoned investors are taking a cautious stance. The stock still carries significant reputational baggage from past accounting controversies, and analysts note that one strong quarter does not erase structural concerns about governance and transparency.
Turning to the Fed, Wednesday's FOMC decision is shaping up as the most closely watched policy moment of the year. New chair Kevin Warsh has deliberately kept markets guessing, signaling he views inflation as still too elevated, yet stopping short of explicitly endorsing a rate hike. That ambiguity is rare and intentional, and it has bond traders on edge heading into the announcement.
Meanwhile at Capricor Therapeutics, a senior executive sold over twenty-four thousand shares at roughly thirty dollars apiece just ahead of a notable pullback in the stock. Karen Krasney, the company's general counsel, pocketed approximately seven hundred thirty-two thousand dollars in the transaction. With a potential catalyst still on the horizon, investors are weighing whether insider selling signals caution or simply routine portfolio management.
That's the tape. Markets Desk, signing off the floor.
